StockCIK 1439222

AGIOS PHARMACEUTICALS, INC. (AGIO): Insider Trades and Fund Holdings

In the past 12 months, AGIOS PHARMACEUTICALS, INC. insiders reported 0 open-market purchases worth $0 and 2 sales worth $75K; 2 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$75KSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 23, 2026.

Recent AGIO insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 23	Oct 21	Sarah GheuensChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	1,489	37.53	$56K	−2.7%	Form 4 ↗
Oct 23	Oct 22	Sarah GheuensChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	500	37.52	$19K	−0.9%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Sarah Gheuens	Chief Medical Officer	0	$0	2	$75K	Oct 23, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →